There were 1,837 press releases posted in the last 24 hours and 442,440 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
FDA grants accelerated approval to zongertinib for non-squamous NSCLC with HER2 TKD activating mutations

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image